DAUNORUBICIN CITRATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for daunorubicin citrate and what is the scope of patent protection?
Daunorubicin citrate
is the generic ingredient in one branded drug marketed by Galen (uk) and is included in one NDA. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for daunorubicin citrate.
Summary for DAUNORUBICIN CITRATE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 6 |
| Clinical Trials: | 3 |
| Patent Applications: | 1,899 |
| DailyMed Link: | DAUNORUBICIN CITRATE at DailyMed |
Recent Clinical Trials for DAUNORUBICIN CITRATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
| Alphacait, LLC | Phase 2 |
| The Emmes Company, LLC | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for DAUNORUBICIN CITRATE
US Patents and Regulatory Information for DAUNORUBICIN CITRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galen (uk) | DAUNOXOME | daunorubicin citrate | INJECTABLE, LIPOSOMAL;INJECTION | 050704-002 | Apr 8, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
